Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2025 ,inter alia, to consider and approve Appointment of Directors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories has called a Board meeting on April 16, 2025, to consider a sweeping overhaul of its leadership team. On the agenda are five new appointments: Shri. Ruchit Mehta as Managing Director and CEO, Shri. Utsav Trivedi as CFO, Ms. Sarvagya Goel and Ms. Shilpi Chopra as Non-Executive Independent Directors, and CS Bhawna Rajput as Company Secretary and Compliance Officer. At the same time, the Board will record the resignations of six people: Mr. Bhavin Sheth (Executive Director and CEO), Shri. Ashok Somani (Executive Director and CFO), Mrs. Shanta Somani (Non-Executive Director), three Non-Executive Independent Directors (Shri. Mathura Prasad Sharma, Shri. Toby Antony, and Shri. Nandkumar Pareek), and Mrs. Unnatti Jain (Company Secretary and Compliance Officer). The intimation is signed by outgoing Director Ashok Somani and is filed under the company's BSE script code 506365.
This is a near-complete leadership turnover, with the CEO, CFO, Company Secretary, and all three Independent Directors exiting in one go while new faces are being inducted. For shareholders, this signals a major restructuring of the company's management and board; while it could bring a fresh strategic direction, the simultaneous exit of nearly all key managerial personnel and independent directors may raise governance and continuity concerns in the short term.